HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

bipiperidyl mustard (BPM)

RN given refers to parent cpd; structure
Also Known As:
BPM; bipiperidyl mustard dihydrochloride; 1,1'-bis(beta-chloroethyl)-4,4'-bipiperidine
Networked: 1423 relevant articles (34 outcomes, 86 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Nattel, Stanley: 9 articles (12/2012 - 01/2002)
2. Ford, Ian: 8 articles (12/2015 - 09/2008)
3. Geyer, Mark A: 8 articles (09/2015 - 10/2009)
4. Young, Jared W: 8 articles (09/2015 - 10/2009)
5. Zareba, Wojciech: 6 articles (10/2015 - 08/2013)
6. Irigoyen, M C: 6 articles (06/2015 - 06/2000)
7. Greenlaw, Nicola: 6 articles (03/2015 - 01/2012)
8. Ferrari, Roberto: 6 articles (09/2014 - 09/2008)
9. Tardif, Jean-Claude: 6 articles (09/2014 - 06/2002)
10. McNitt, Scott: 5 articles (09/2015 - 08/2013)

Related Diseases

1. Bradycardia
2. Tachycardia (Tachyarrhythmias)
3. Breast Neoplasms (Breast Cancer)
4. Weight Loss (Weight Reduction)
5. Insulin Resistance
08/01/2011 - "It was shown that the efficacy of moxonidine in reducing insulin resistance in patients with metabolic syndrome directly depends on the severity of hypersympathicotonia manifesting in heart rate over 80 bpm at rest."
02/01/2009 - "Baseline higher heart rate (heart rate >or=80 bpm in 1979) predicted the development of obesity, diabetes mellitus (DM), and insulin resistance in 1999 after adjustments for age, sex, and other confounders. "
05/01/2014 - "Relative to usual care or no intervention, yoga improved systolic (mean difference (MD)=-5.85 mm Hg; 95% confidence interval (CI)=-8.81, -2.89) and diastolic blood pressure (MD=-4.12 mm Hg; 95%CI=-6.55, -1.69), heart rate (MD=-6.59 bpm; 95%CI=-12.89, -0.28), respiratory rate (MD=-0.93 breaths/min; 95%CI=-1.70, -0.15), waist circumference (MD=-1.95 cm; 95%CI=-3.01, -0.89), waist/hip ratio (MD=-0.02; 95%CI=-0.03, -0.00), total cholesterol (MD=-13.09 mg/dl; 95%CI=-19.60, -6.59), HDL (MD=2.94 mg/dl; 95%CI=0.57, 5.31), VLDL (MD=-5.70 mg/dl; 95%CI=-7.36, -4.03), triglycerides (MD=-20.97 mg/dl; 95%CI=-28.61, -13.32), HbA1c (MD=-0.45%; 95%CI=-0.87, -0.02), and insulin resistance (MD=-0.19; 95%CI=-0.30, -0.08). "
08/01/2015 - "In less inflamed OW/OB [high-sensitivity C-reactive protein (hsCRP) <1.5], statistically significant decreases occurred in weight (-1.1 ± 0.5 kg), waist circumference (-3.1 ± 1.4 cm), diastolic blood pressure (-4.1 ± 1.6 mmHg), heart rate [HR; -4.0 ± 1.7 beats per minute (bpm)], triglycerides (-72 ± 38.2 mg/dl), insulin resistance (homeostatic model of insulin resistance) (-0.72 ± 0.3), and insulin (-2.8 ± 1.3 mU/L); an increase in HDL-2b (+303 ± 116 nM) and realignment of LDL lipid subfractions toward a less atherogenic profile [decreased small LDL IIIb (-44 ± 23.5 nM), LDL IIIa (-99 ± 43.7 nM), and increased large LDL I (+66 ± 28.0 nM)]. "

Related Drugs and Biologics

1. Oxygen
2. ivabradine
3. Lactic Acid
4. polycaprolactone
5. Cholesterol
6. Triglycerides (Triacylglycerol)
7. moxonidine (Moxon)
8. Metoprolol (Lopressor)
9. Ephedrine
10. Enoximone

Related Therapies and Procedures

1. Defibrillators (Defibrillator)
2. Mastectomy (Mammectomy)
3. Cardiac Resynchronization Therapy
4. Stents
5. Implantable Defibrillators (Implantable Cardioverter-Defibrillator)